In conclusion, the findings of this study suggest that HCSP4-Lipo-DOX-miR101 may serve as a promising novel targeted delivery system for improving the therapeutic efficiency of drug-resistant hepatocellular carcinoma.Rhenium dichalcogenides (ReX2, X = S, Se), as a representative type of T”-phase transition metal dichalcogenides (TMDs), have a…[Read more]